Southern California Evidence-Based Practice Center/RAND, United States. Agency for Healthcare Research and Quality, & Newberry, S. J. (2004). Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality.
Cita Chicago Style (17a ed.)Southern California Evidence-Based Practice Center/RAND, United States. Agency for Healthcare Research and Quality, y Sydne J. Newberry. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2004.
Cita MLA (9a ed.)Southern California Evidence-Based Practice Center/RAND, et al. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2004.
